Drug and substance use disorders affect millions of Americans and their families, creating significant challenges for individuals, communities, and healthcare systems. Understanding these complex conditions—including their causes, warning signs, and treatment options—is essential for promoting recovery and reducing the devastating impacts of addiction.
According to the 2023 National Survey on Drug Use and Health (NSDUH), approximately 7.7% of United States individuals aged 18 or older had a substance use disorder in the past year. This represents millions of people struggling with addiction to alcohol, prescription medications, or illicit drugs. Despite the prevalence of these disorders, effective treatments are available, and recovery is possible with appropriate support and evidence-based interventions.
Table of Contents
- Understanding Substance Use Disorders
- Warning Signs and Symptoms
- Risk Factors and Causes
- The Opioid Crisis: Current Trends
- Co-occurring Mental Health Conditions
- Impact on Families and Communities
- Evidence-Based Treatment Approaches
- Medical Complications and Health Risks
- Frequently Asked Questions
- How Therapy Can Help
Understanding Substance Use Disorders
A substance use disorder (SUD) is a medical condition characterized by the recurrent use of alcohol or drugs that causes clinically significant impairment, including health problems, disability, and failure to meet major responsibilities at work, school, or home. SUD is a medical condition characterized by an impaired ability to stop or control substance use despite adverse social, occupational, or health consequences. It encompasses conditions that some people refer to as substance abuse, substance dependence, substance addiction, and related colloquial terms. SUD can be mild, moderate, or severe.
Lasting changes in the brain caused by substance misuse perpetuate SUD and make individuals vulnerable to relapse. These neurobiological changes affect decision-making, impulse control, and the brain's reward system, making it extremely difficult for individuals to stop using substances even when they desperately want to quit.
The distinction between substance misuse and addiction involves several factors. While misuse refers to any use that causes harm or puts someone at risk, addiction represents a chronic brain disorder marked by compulsive substance use despite harmful consequences. Individual paths to recovery vary widely, and the majority of people with SUD reduce or resolve their substance use problems over time.
Warning Signs and Symptoms
Early Warning Signs of Substance Misuse
Recognizing the early signs of substance misuse can lead to earlier intervention and better outcomes. Common warning signs include:
- Behavioral changes: Neglecting responsibilities at work, school, or home
- Social withdrawal: Isolating from family and friends who don't use substances
- Physical symptoms: Changes in appetite, sleep patterns, or unexplained weight loss/gain
- Psychological signs: Mood swings, irritability, or personality changes
- Financial problems: Spending excessive money on substances or borrowing money frequently
- Legal issues: Arrests for driving under the influence or drug-related offenses
Progression to Substance Use Disorder
As substance use escalates, individuals may experience:
- Tolerance: Needing increasing amounts to achieve the same effect
- Withdrawal symptoms: Physical or psychological discomfort when not using
- Loss of control: Using more than intended or for longer periods than planned
- Continued use despite consequences: Persisting even after experiencing health, relationship, or legal problems
- Preoccupation: Spending significant time obtaining, using, or recovering from substance use
- Failed attempts to quit: Multiple unsuccessful efforts to reduce or stop use
Risk Factors and Causes
Genetic Factors
A complex interplay of genetic and environmental factors influences a person's risk for SUD. Between 50% and 60% of the vulnerability to SUD is inherited. This risk is likely due to common variants in many genes, each of small effect.
Recent research has identified specific genetic markers associated with addiction risk. Substance use disorders are heritable and influenced by complex interactions among multiple genes and environmental factors. In one study, researchers used genome-wide association methods to pinpoint areas in the genome associated with general addiction risk, as well as the risk of specific substance use disorders—namely, alcohol, nicotine, cannabis, and opioid use disorders—in a sample of 1,025,550 individuals with genes indicating European ancestry and 92,630 individuals with genes indicating African ancestry.
The findings also reinforce the role of the dopamine system in addiction, by showing that the combination of genes underlying addiction disorders was also associated with regulation of dopamine signaling. This discovery helps explain why some individuals may be more susceptible to developing substance use disorders than others.
Environmental Risk Factors
Environmental factors play a crucial role in substance use disorder development:
- Trauma and stress: Among the environmental risk factors for SUD, external stress is one of the most potent. Patients who experienced trauma, particularly in childhood, or an accumulation of significant stressors throughout life, may be prone to heavy substance use patterns and increased SUD risk
- Early exposure: Initiating substance use during adolescence increases addiction risk
- Peer influence: Social circles that normalize or encourage substance use
- Availability: Easy access to alcohol or drugs in the community
- Family dynamics: Growing up in households with substance use problems
- Socioeconomic factors: Poverty, unemployment, and limited educational opportunities
Neurobiological Mechanisms
Addiction involves changes in brain structure and function, particularly in areas responsible for:
- Reward processing and motivation
- Executive function and decision-making
- Stress response and emotional regulation
- Learning and memory
These changes explain why addiction is considered a chronic brain disorder rather than simply a lack of willpower or moral failing.
The Opioid Crisis: Current Trends
Recent Developments and Statistics
The United States has experienced significant changes in opioid-related deaths recently. New provisional data from CDC's National Vital Statistics System predicts a nearly 24% decline in drug overdose deaths in the United States for the 12 months ending in September 2024, compared to the previous year. Provisional data shows about 87,000 drug overdose deaths from October 2023 to September 2024, down from around 114,000 the previous year. This is the fewest overdose deaths in any 12-month period since June 2020.
Despite this encouraging decline, approximately 105,000 people died from drug overdose in 2023, and nearly 80,000 of those deaths involved opioids (about 76%). The crisis continues to evolve, with synthetic opioids playing an increasingly dominant role.
Understanding the Three Waves
This rise in opioid overdose deaths can be outlined in three distinct waves. The first wave began with increased prescribing of opioids in the 1990s. The second wave began in 2010, with rapid increases in overdose deaths involving heroin. The third wave began in 2013, with substantial increases in overdose deaths involving synthetic opioids, particularly those involving illegally made fentanyl and fentanyl analogs (IMFs).
Current Drug Supply Dangers
IMFs have largely saturated the illegal drug supply. They are often found in powder form or pressed into counterfeit pills and can have other drugs mixed into them. More recently, non-opioid sedatives, such as xylazine, have been found mixed into IMFs. This contamination of the drug supply significantly increases overdose risk, as users may unknowingly consume lethal doses of fentanyl.
Recognizing Opioid Overdose
Immediate recognition of overdose symptoms saves lives. Key signs include:
- Extremely slow or stopped breathing
- Unresponsiveness to stimuli
- Blue lips or fingernails
- Gurgling or choking sounds
- Limp body
- Pale, clammy skin
Naloxone (Narcan) can reverse opioid overdoses and is now available without prescription in many states. Anyone who uses opioids or knows someone who does should have naloxone readily available.
Co-occurring Mental Health Conditions
High Rates of Comorbidity
Data show high rates of comorbid substance use disorders and anxiety disorders—which include generalized anxiety disorder, panic disorder, and post-traumatic stress disorder. Substance use disorders also co-occur at high prevalence with mental disorders, such as depression and bipolar disorder, attention-deficit hyperactivity disorder (ADHD), psychotic illness, borderline personality disorder, and antisocial personality disorder.
The relationship between mental health and substance use is complex and bidirectional:
- Mental health symptoms may lead to self-medication with substances
- Substance use can trigger or worsen mental health conditions
- Both conditions may share common underlying vulnerabilities
Prevalence Statistics
Recent data reveals the scope of co-occurring disorders:
- Drug abuse often results in comorbidity; nearly 45% of persons who have substance abuse disorder also experience mental illness
- Adults with SMI: 51.9% used illicit drugs in the past year. Adults with AMI: 42.4% used illicit drugs. Adults with no mental illness: 21.0% used illicit drugs
- Nearly half (46.9%) of young adults aged 18-25 in the U.S. had either a mental illness or a substance use disorder in the past year
Integrated Treatment Approach
Effective treatment for co-occurring disorders requires addressing both conditions simultaneously. This integrated approach may include:
- Coordinated mental health and addiction treatment
- Medications for both conditions when appropriate
- Specialized therapy approaches designed for dual diagnosis
- Peer support groups for people with co-occurring disorders
- Family education and involvement
Impact on Families and Communities
Effects on Children
Over 7 million children in the United States—more than 10%—live with a parent who has problems with alcohol, according to a 2012 Substance Abuse and Mental Health Services Administration report. While this statistic needs updating, it highlights the widespread impact on families.
Children in families affected by substance use disorders may experience:
- Emotional challenges: Anxiety, depression, and behavioral problems
- Academic difficulties: Poor school performance and higher dropout rates
- Developmental impacts: Disrupted attachment and delayed emotional development
- Increased risk: Higher likelihood of developing substance use disorders themselves
- Role reversal: Taking on adult responsibilities prematurely
Family System Disruption
Substance use disorders affect entire family systems through:
- Financial strain: Job loss, legal costs, and treatment expenses
- Relationship damage: Trust issues, communication breakdowns, and potential violence
- Enabling behaviors: Family members inadvertently supporting continued use
- Codependency: Unhealthy relationship patterns that maintain dysfunction
- Intergenerational trauma: Passing trauma and addiction risk to future generations
Community-Level Impacts
The ripple effects extend beyond individual families:
- Economic costs: The annual economic impact of substance misuse is estimated to be $249 billion for alcohol misuse and $193 billion for illicit drug use. Substance use disorders cost U.S. hospitals an estimated $13.2 billion in a single year (2018), with alcohol-related disorders accounting for the largest share at $7.6 billion
- Healthcare burden: Emergency department visits, hospitalizations, and chronic disease management
- Criminal justice involvement: Incarceration, court costs, and recidivism
- Workplace impacts: Lost productivity, absenteeism, and workplace accidents
- Community safety: Impaired driving, violence, and property crime
Evidence-Based Treatment Approaches
Cognitive Behavioral Therapy (CBT)
CBT produced small to moderate effects on substance use when compared to inactive treatment and was most effective at early follow-up (1–6 months post-treatment). A "strong recommendation" was provided for CBT as an empirically supported treatment for SUD, based on effects on substance use, quality of evidence, and consideration of contextual factors.
CBT for substance use disorders focuses on:
- Identifying triggers and high-risk situations
- Developing coping strategies
- Challenging negative thought patterns
- Building problem-solving skills
- Preventing relapse through skills practice
Contingency Management
Results of the current meta-analysis provide new information to the field. Specifically, focusing on urine toxicology results, this meta-analysis found a significant long-term effect for CM, directly addressing the common concern that the effects of CM disappear once reinforcers are no longer provided.
Contingency management involves:
- Providing tangible rewards for positive behaviors
- Frequent drug testing with immediate feedback
- Escalating incentives for continued abstinence
- Vouchers or prizes for meeting treatment goals
- Strong evidence for effectiveness with stimulant use disorders
Motivational Interviewing
Small benefits were observed for significant others involved in treatment, motivational interviewing, and the combination of cognitive-behavioral therapy with motivational interviewing for alcohol use disorder.
This approach emphasizes:
- Building intrinsic motivation for change
- Resolving ambivalence about treatment
- Supporting self-efficacy
- Non-confrontational therapeutic style
- Collaboration between therapist and client
Technology-Based Interventions
Based on 130 studies, the overall between-group effect size was 0.23 (95% CI = 0.18, 0.28) for technology-based interventions among emerging adults and college students.
Modern treatment increasingly incorporates:
- Mobile apps for recovery support
- Online therapy platforms
- Virtual support groups
- Text-based check-ins and reminders
- Digital therapeutic programs
Medication-Assisted Treatment (MAT)
For opioid and alcohol use disorders, medications can be life-saving:
- Opioid use disorder: Buprenorphine, methadone, and naltrexone
- Alcohol use disorder: Naltrexone, acamprosate, and disulfiram
- Combined approach: Medications work best with behavioral therapy
Medical Complications and Health Risks
Physical Health Consequences
Chronic substance use can damage nearly every organ system:
Cardiovascular effects:
- Heart disease and stroke
- Irregular heartbeat
- High blood pressure
- Collapsed veins (injection drug use)
Liver damage:
- Cirrhosis and liver failure
- Fatty liver disease
- Hepatitis (especially with injection drug use)
Respiratory problems:
- Lung infections
- Chronic bronchitis
- Increased risk of pneumonia
- Overdose-related respiratory failure
Neurological impacts:
- Cognitive impairment and memory problems
- Increased risk of dementia
- Seizures
- Peripheral neuropathy
Infectious Disease Risks
High-risk behaviors and drug abuse also result in much higher chances of contracting viral infections such as hepatitis or HIV. Abusers who inject their drugs account for 7% of HIV diagnoses.
Prevention strategies include:
- Sterile syringe programs
- HIV and hepatitis testing
- Pre-exposure prophylaxis (PrEP) for high-risk individuals
- Vaccination for hepatitis A and B
- Linkage to infectious disease treatment
Overdose Prevention
Beyond naloxone availability, comprehensive overdose prevention includes:
- Education about overdose risks
- Never using alone
- Testing drugs for fentanyl contamination
- Starting with small doses after periods of abstinence
- Avoiding mixing substances, especially depressants
Frequently Asked Questions
What's the difference between substance abuse and substance use disorder?
Substance abuse refers to any use that causes harm or puts someone at risk, while substance use disorder is a medical diagnosis involving compulsive use despite negative consequences. The term "substance use disorder" is now preferred as it reduces stigma and acknowledges addiction as a medical condition rather than a moral failing.
Can someone recover from addiction without professional help?
While some people do recover without formal treatment, professional help significantly improves outcomes. People with SUD can receive effective, science-backed treatment in a variety of settings, including primary care. Treatment provides tools, support, and medical care that can be crucial for lasting recovery.
How long does addiction treatment typically last?
Treatment duration varies based on individual needs. Operational definitions, metrics, and criteria used were overall inconsistent across studies, but research shows longer treatment engagement generally leads to better outcomes. Many people benefit from ongoing support even after completing initial treatment.
Is addiction really a disease?
Yes, major medical organizations recognize addiction as a chronic brain disease. Lasting changes in the brain caused by substance misuse perpetuate SUD and make individuals vulnerable to relapse. Like other chronic diseases, it requires ongoing management and can include periods of relapse and remission.
What role does family play in recovery?
Family involvement can significantly impact recovery success. Family therapy helps address relationship damage, improve communication, and create a supportive home environment. However, recovery is ultimately an individual process, and family members also need their own support.
Are certain people more likely to become addicted?
Yes, risk varies based on genetic factors, environmental influences, age of first use, and mental health status. Between 50% and 60% of the vulnerability to SUD is inherited, though having genetic risk doesn't guarantee someone will develop addiction.
How Therapy Can Help
Professional therapy provides essential support for overcoming substance use disorders. A skilled therapist can help individuals:
- Understand underlying issues: Explore trauma, mental health conditions, or life circumstances contributing to substance use
- Develop coping strategies: Learn healthy ways to manage stress, emotions, and cravings
- Repair relationships: Work through family conflicts and rebuild trust
- Build recovery skills: Develop relapse prevention plans and lifestyle changes
- Address co-occurring conditions: Treat mental health issues alongside addiction
Finding the right therapist is crucial. Look for professionals with:
- Specialized training in addiction treatment
- Experience with evidence-based approaches
- Understanding of co-occurring disorders
- A non-judgmental, supportive approach
- Appropriate licensure and credentials
The GoodTherapy directory can help you find qualified addiction specialists in your area who match your specific needs and preferences.
References:
- Centers for Disease Control and Prevention. (2025, February 25). CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths. CDC Newsroom. https://www.cdc.gov/media/releases/2025/2025-cdc-reports-decline-in-us-drug-overdose-deaths.html
- Centers for Disease Control and Prevention. (2025, July 13). Understanding the Opioid Overdose Epidemic. https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html
- Delgado-Lobete, L., et al. (2025). Novel Insights into Addiction Management: A Meta-Analysis on Intervention for Relapse Prevention. Medicina, 61(4), 619. https://doi.org/10.3390/medicina61040619
- Garnett, M. F., & Miniño, A. M. (2024). Drug Overdose Deaths in the United States, 2023–2024. NCHS Data Brief, no. 549. National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db549.htm
- Ginley, M. K., et al. (2021). Long-Term Efficacy of Contingency Management Treatment Based on Objective Indicators of Abstinence From Illicit Substance Use up to 1 Year Following Treatment: A Meta-Analysis. Journal of Consulting and Clinical Psychology, 89(1), 58-71. https://doi.org/10.1037/ccp0000552
- Hatoum, A. S., et al. (2023). Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders. Nature Mental Health, 1, 210–223. https://doi.org/10.1038/s44220-023-00034-y
- Martinez-Loredo, V., et al. (2023). Meta-review on the efficacy of psychological therapies for the treatment of substance use disorders. Psychiatry Research, 326, 115-268. https://doi.org/10.1016/j.psychres.2023.115268
- McHugh, R. K., et al. (2023). An Evaluation of Cognitive Behavioral Therapy for Substance Use Disorder: A Systematic Review and Application of the Society of Clinical Psychology Criteria for Empirically Supported Treatments. Journal of Consulting and Clinical Psychology, 91(10), 589-602. https://doi.org/10.1037/ccp0000831
- Narváez-Camargo, M., et al. (2025). Substance Use Disorder Treatment Outcomes: Methodological Overview of Metrics and Criteria. International Journal of Methods in Psychiatric Research, 34(1), e70027. https://doi.org/10.1002/mpr.70027
- National Institute on Alcohol Abuse and Alcoholism. (2024). Mental Health Issues: Alcohol Use Disorder and Common Co-occurring Conditions. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/mental-health-issues-alcohol-use-disorder-and-common-co-occurring-conditions
- National Institute on Alcohol Abuse and Alcoholism. (2024). Understanding Alcohol Drinking Patterns. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-drinking-patterns
- National Institute on Alcohol Abuse and Alcoholism. (2025). Alcohol Use Disorder: From Risk to Diagnosis to Recovery. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/alcohol-use-disorder-risk-diagnosis-recovery
- National Institute on Alcohol Abuse and Alcoholism. (2025). Risk Factors: Varied Vulnerability to Alcohol-Related Harm. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/risk-factors-varied-vulnerability-alcohol-related-harm
- National Institute on Drug Abuse. (2023). Common Comorbidities with Substance Use Disorders Research Report. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK571451/
- National Institute on Drug Abuse. (2025, June 11). Drug Overdose Deaths: Facts and Figures. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
- National Institute on Mental Health. (2023). New NIH Study Reveals Shared Genetic Markers Underlying Substance Use Disorders. https://www.nimh.nih.gov/news/science-updates/2023/new-nih-study-reveals-shared-genetic-markers-underlying-substance-use-disorders
- Peterson, C., et al. (2021). Assessment of Annual Cost of Substance Use Disorder in US Hospitals. JAMA Network Open, 4(3), e210242. https://doi.org/10.1001/jamanetworkopen.2021.0242
- Substance Abuse and Mental Health Services Administration. (2024). Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP24-07-021, NSDUH Series H-59). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/report/2023-nsduh-annual-national-report
- Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health
- Wang, Y., et al. (2024). Technology-Based Substance Use Interventions for Emerging Adults and College Students: A Systematic Review and Meta-Analysis. International Journal of Mental Health and Addiction. https://doi.org/10.1007/s11469-024-01433-7
